The U.S. Supreme Court ruled against President Trump on Tuesday, refusing to reinstate, for now, Trump's ability to send National Guard troops into the state of Illinois over the objections of the governor.
-
A worker was rescued after becoming suspended while trimming a tree Sunday in Doña Ana.
-
Susan Morée speaks with MaryEllen Garcia, executive director of NMCADV about the organizations funding needs and the prevalence of domestic violence in the state.
-
El Rito Media Publisher Josh Byers covers top stories each week on Alamogordo NOW.
-
KC Counts speaks with Steinborn about the amendment that allows data centers to consider power generation as individual sources, skirting environmental law.
-
CYFD has requested a 4.7% increase to their budget from the New Mexico state legislature totaling $422.3 million.
-
The U.S. Bureau of Reclamation has set a new deadline of Feb. 14, but it appears unlikely the states will reach agreement that quickly, according to Nevada's lead negotiator.
-
Trump and Republicans in Congress say the rate reset will boost energy production, jobs and affordability as the administration clears the way for expanded drilling and mining on public lands.
-
Rodriguez joins a GOP field that includes Rio Rancho Mayor Gregg Hull and state Sen. Steve Lanier of Aztec.
-
Though an asylum request was rejected, Ziaei was released in mid-2024 with authorization to work based on concerns he would be persecuted if returned to Iran.
-
Scientists have developed an experimental way to study how human embryos implant in a uterus, which may provide new insights into why miscarriages occur and how they can be prevented.
-
Photographs help us look back on the moments that defined the year. Taken by NPR photojournalists nationwide, this collection goes beyond the headlines to reveal quietly powerful human stories.
-
Budget shortfalls and nearly $1 trillion in looming federal Medicaid cuts have prompted states to rein in spending on a widely embraced autism therapy, pinching families who depend on the services.
-
The data, which was delayed from October by the government shutdown, comes as the economy takes center stage for voters and the Trump administration.
-
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.